BIOMUNE
Vaccines  

Home
About Biomune
Products
Research
Manufacturing
Distribution
News
Sitemap
Contact Us

PSITTIMUNE ® APV
Avian Polyomavirus Vaccine, Killed Virus

Description
Psittimune APV contains inactivated avian polyomavirus.

Indications
Psittimune APV is recommended for the vaccination of selected psittacine birds as an aid in the prevention of avian polyomavirus infection or budgerigar fledgling disease.

Psittimune APV is administered by the subcutaneous method to healthy, susceptible psittacine birds prior to the laying season, during quarantine, and prior to exposure to other psittacine stock or equipment. Young birds are vaccinated at 5 weeks of age. Larger psittacine birds weighing 200 grams or greater should receive a 0.5 ml dose. Birds weighing less that 200 grams should receive a 0.25 ml dose.


Patent No. 5,747,045


(c) Biomune Co.
Privacy Statement / Legal Notice